Salarius Pharmaceuticals (SLRX) announced that it will effect a 1-for-15 reverse stock split at 5:00 p.m. Eastern Time, on August 15, 2025. Beginning with the opening of trading on August 18, 2025, Salarius’ common stock will trade on the Nasdaq Capital Market on a split-adjusted basis under a new CUSIP number 79400X503.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SLRX:
- Salarius Pharmaceuticals Raises $3.8M Through Stock Sale
- Salarius Pharmaceuticals Modifies Security Holders’ Rights
- Why is Penny Stock Salarius Pharmaceuticals (SLRX) Up 182% Today?
- Salarius Pharmaceuticals Granted Nasdaq Compliance Extension
- Salarius granted additional extension to regain Nasdaq compliance